Boots sale to Wittington: flat UK profit, $8.9 billion price and $4.3 billion debt
Boots UK Limited reported operating profit of £355 million for the year to August 2025, including a £115 million impairment reversal booked after Sycamore bought the group. Underlying profit was £240 million, against £242 million a year earlier. Wittington and Fairfax are paying about 28 times that UK company's underlying profit, with roughly $4.3 billion borrowed.
Wittington Investments has agreed to buy Boots for $8.9 billion, including assumed debt, according to its release. Fairfax will commit up to about $2.3 billion for half of the equity, while Wittington retains operational control. The seller is The Boots Group, majority-owned by Sycamore Partners alongside Stefano Pessina and his family. Sycamore has owned the group for about 13 months.
If the other half of the equity matches Fairfax's commitment, the total equity would be about $4.6 billion and the debt about $4.3 billion, roughly 48% of the price. The debt will sit on a UK operating company whose underlying profit was flat last year. Boots' reported earnings do not support the price. The buyers are paying for control of its stores and licences, with borrowing covering about half the cost and current profit only just covering that debt.
The clearest record is Boots UK Limited's full accounts for the year to 31 August 2025, audited by Deloitte and filed at Companies House on 6 June 2026. Revenue rose 3.2% to £7,545 million, and gross profit increased £90 million to £2,771 million. Operating profit rose from £274 million to £355 million, a 30% gain. At the headline level, the business improved in the year it was sold.
The strategic report explains why the increase does not show stronger underlying profit. The 2024 figure included a £219 million past-service pension credit and a £187 million impairment charge. The 2025 figure included a £115 million impairment reversal. The report says it followed an asset valuation exercise using acquisition fair values, performed for the group's acquisition, alongside consistent trading performance. Of the reversal, £79 million related to pharmacy licences, which had carried a £129 million charge a year earlier. Excluding those items, operating profit was £242 million in 2024 (£274 million less £219 million plus £187 million) and £240 million in 2025 (£355 million less £115 million). Reported profit rose £81 million; underlying profit fell £2 million.
The reversal restores value to assets written down a year earlier. Pharmacy licences took a £129 million charge in 2024 and a £79 million write-back in 2025, while the trading result beneath them barely changed. Revenue and gross profit did rise, supporting the case for the price: comparable-store retail sales increased 5.8% and Boots.com grew 18.3%. Those gains are already reflected in the £240 million of underlying profit. The report says £90 million of gross-margin improvement was partly offset by £44 million of higher costs on major IT projects, with general cost increases absorbing the rest. Sales growth that costs as much as it earns does not service debt.
At the 7 October exchange rate of $1.3216 to the pound, $8.9 billion equals about £6.73 billion. That is 28 times underlying operating profit, or 19 times reported profit of £355 million. The purchase perimeter matters: Wittington is buying the UK and Ireland retail business, Boots Opticians, No7 Beauty Company, and the Thailand and franchised businesses. Boots UK Limited is only the largest part. Dividing the full price by the UK operating company's profit gives the 28-times figure; the multiple on all the acquired businesses is lower, but published accounts do not quantify it.
The debt is the more demanding figure. The implied $4.3 billion equals about £3.25 billion, or 13.5 times the £240 million of underlying operating profit. That is before £1,465 million of lease liabilities: £175 million current and £1,290 million non-current. Boots UK paid £96 million of lease interest during the year, up from £87 million, and recorded £210 million of depreciation on right-of-use assets. Operating profit is measured after that depreciation but before interest. The £240 million must therefore cover lease interest first, then the acquisition loan being arranged by CIBC and Morgan Stanley Senior Funding. Each percentage point of interest on £3.25 billion costs £32.5 million a year. After lease interest, £144 million remains, which any rate above about 4.4% would use up. The syndicated loan would be backed by cash flow that has not grown and would fund growth that has yet to show up in profit.
Fairfax's commitment is modest relative to its size. It equals 8.8% of the $26.0 billion in common shareholders' equity reported in its second-quarter results. Those results show the holding company had $2.3 billion in cash and marketable securities at 30 June, about the size of its entire Boots commitment. Its $71.7 billion in portfolio investments sits in insurance and reinsurance companies. The holding company can deploy cash without using policyholder capital, and the Boots commitment would use almost all of it. The Weston family's side has a longer record. Galen Weston will become chairman, and Wittington plans store upgrades, online growth and healthcare services. Walgreens Boots Alliance ended a strategic review in June 2022 by deciding to keep Boots. Sycamore then bought all of Walgreens Boots Alliance, including its US business, with about $18.8 billion in funding, $13.33 billion of it committed debt, according to the proxy statement. Boots has changed hands twice in 13 months, with debt financing a large share of the cost both times.
The price depends on Wittington turning store upgrades and online growth into operating profit faster than it did last year, when revenue rose 3.2% but underlying profit fell £2 million. The 2026 accounts will cover Boots' first year as a standalone company. Sycamore's Stefan Kaluzny said in the release that Sycamore had "re-established Boots as a standalone company" a year ago. The IT projects that absorbed half of the 2025 gross-margin gain are among the costs that separation adds rather than removes.
The first test falls on lenders, not equity investors. Boots UK Limited's accounts for the year to August 2026 are due at Companies House by 31 May 2027. They will show underlying operating profit below £260 million, leaving the purchase price at about 26 times profit or more and implied debt above 12 times profit.